Skip to main content
. 2024 Dec 4;7(12):e70232. doi: 10.1002/hsr2.70232

Table 1.

Diagnostic criteria of GBS; acute inflammatory demyelinating polyneuropathy and acute motor axonal neuropathy [1].

Features required for diagnosis of GBS
Progressive weakness in legs and arms (sometimes initially only in legs)
Areflexia (or decreased tendon reflexes) in weak limbs
Acute inflammatory demyelinating polyneuropathy (AIDP)
Additional symptoms Nerve conduction study findings
Progressive phase lasts days to 4 weeks Features of demyelination (only assessable if distal CMAP amplitude is > 10% LLN)
Relative symmetry of symptoms Prolonged distal motor latency
Mild sensory symptoms or signs Decreased motor nerve conduction velocity
Cranial nerve involvement, especially bilateral weakness of facial muscles Increased F‐wave latency, conduction blocks and temporal dispersion
Autonomic dysfunction
Pain (often)
Acute motor axonal neuropathy (AMAN)
Additional symptoms Nerve conduction study findings
Progressive phase lasts days to 4 weeks No features of demyelination (or, one demyelinating feature in one nerve if distal CMAP amplitude is < 10% LLN)
Relative symmetry of symptoms Distal CMAP amplitude is < 80% LLN in at least two nerves
No sensory symptoms or signs Transient motor nerve conduction block may be present (possibly caused by antiganglioside antibodies)
Cranial nerve involvement (rarely) No features of demyelination (or, one demyelinating feature in one nerve if distal CMAP amplitude is < 10% LLN)
Autonomic dysfunction
Pain (sometimes)